Key Takeaways
- ARK Invest divested 3,578 Meta (META) stock shares valued at approximately $2.1 million from three separate funds
- The firm liquidated 95,090 Roku (ROKU) stock shares worth roughly $9.1 million across several ETFs
- ARK acquired 84,939 Tempus AI (TEM) stock shares for about $4.1 million on March 25
- Tempus AI now represents the third-largest position in ARK Innovation ETF at approximately 5% portfolio weight
- Meta faced a social media addiction lawsuit verdict and announced workforce reductions affecting hundreds
Cathie Wood’s investment firm ARK Invest reduced holdings in Meta Platforms and Roku on March 25, redirecting capital toward healthcare artificial intelligence firm Tempus AI.
The firm offloaded 3,578 shares of Meta (META) stock distributed across three ETFs. At Wednesday’s closing price, the transaction totaled approximately $2.1 million. Following this divestment, ARK Innovation ETF maintains a position of about 105,000 Meta shares valued near $63 million—representing roughly 1% of fund assets.
Meta experienced significant developments that day. A jury delivered a verdict holding both the company and Google’s YouTube accountable for negligence related to products causing harm to young users in a groundbreaking social media addiction case. Both tech giants announced intentions to pursue appeals.
Meta simultaneously introduced a new compensation structure for executives targeting 500% stock appreciation and a $9 trillion market capitalization by 2031. The social media giant confirmed to Barron’s that workforce reductions would affect several hundred employees spanning sales, talent acquisition, and virtual reality departments. Despite these developments, Meta (META) stock closed with a modest 0.3% gain.
ARK simultaneously liquidated 95,090 shares of Roku (ROKU) stock across its ARKK, ARKW, and ARKF portfolios, generating approximately $9.1 million. This transaction followed another substantial Roku divestment executed the previous trading day on March 24.
Additional sales included 30,174 Teradyne shares worth roughly $9.7 million, along with 205,019 Bullish shares distributed across three ETFs totaling about $7.7 million. The investment firm has maintained a consistent pattern of reducing Bullish holdings throughout the past week.
Further transactions included exits from 62,393 Kratos Defense shares and 27,647 Natera shares, valued at $4.8 million and $5.4 million respectively.
ARK Significantly Increases Tempus AI Holdings
Regarding acquisitions, ARK’s primary transaction focused on Tempus AI. The investment firm purchased 84,939 shares through its ARKK and ARKG portfolios, allocating roughly $4.1 million.
Tempus AI (TEM) stock declined 4.2% during Wednesday’s session and has fallen 21% year-to-date in 2026. ARK’s purchase appears strategically timed to capitalize on the price weakness.
ARK Innovation ETF currently maintains approximately 6.3 million Tempus AI shares worth over $294 million. This positions the healthcare AI company as the portfolio’s third-largest holding, trailing only Tesla and Crispr Therapeutics, at approximately 5% of total fund allocation.
Strategic Portfolio Rebalancing Continues
ARK’s March 25 transactions reflect an ongoing strategic shift. The firm has systematically decreased exposure to Roku, Teradyne, and Bullish across multiple consecutive trading sessions.
Concurrently, the investment manager has aggressively accumulated Tempus AI shares. The company specializes in healthcare technology platforms leveraging artificial intelligence for medical data analysis and oncology treatment optimization.
Smaller acquisitions executed that day encompassed shares of Archer Aviation, Beam Therapeutics, and additional holdings.
The ARK Innovation ETF concluded Wednesday’s trading session with a 1.3% advance.
